Brief Psychotherapy + Mobile App for Suicide Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to prevent suicide in individuals recently hospitalized for mental health reasons. The goal is to ensure therapy skills are accessible during stressful times by combining brief psychotherapy sessions with a mobile app (Suicide Prevention App). This method aims to provide support that remains easy to follow and effective, even during crises. Eligible participants should have recently been admitted to a partner hospital due to suicide risk, speak English, and own a smartphone with internet access. As an unphased trial, this study offers a unique opportunity to contribute to innovative mental health solutions.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this psychotherapy and mobile app intervention is safe for suicide prevention?
Research has shown that the Unified Protocol, a type of therapy, is generally easy for people to handle. This treatment addresses emotional problems and is used for various emotional disorders. Studies have found it effective for different groups, suggesting it is adaptable and safe.
While specific safety information about using the Unified Protocol to prevent suicide is lacking, it has been studied for other emotional issues. These studies report no major serious side effects, which is encouraging. This indicates that those who have tried this approach generally did not experience major problems.
In summary, the Unified Protocol appears to be a safe option for many, based on existing research. However, discussing any concerns with healthcare professionals before starting a new treatment is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about the Unified Protocol for suicide prevention because it integrates brief psychotherapy with a mobile app, offering a flexible and accessible approach to mental health care. Unlike traditional treatments that often require long-term therapy sessions, this method provides targeted support in just three sessions, making it more feasible for individuals with busy schedules. Additionally, the use of a mobile app allows for real-time intervention and support, which can be crucial for individuals experiencing acute distress. This combination of brief therapy and digital support aims to deliver effective, timely assistance to those in need.
What evidence suggests that this trial's treatments could be effective for suicide prevention?
Research has shown that the Unified Protocol, which participants in this trial will receive, can greatly improve symptoms of depression and anxiety. It reduces negative feelings and enhances overall quality of life. Studies have found it to be as effective as treatments focusing on specific disorders. This method teaches skills to manage emotions, proving very helpful during a crisis. Early findings suggest it might be a promising option for people at high risk of suicide.13678
Who Is on the Research Team?
Evan Kleiman
Principal Investigator
Rutgers, The State University of New Jersey
Are You a Good Fit for This Trial?
This trial is for adults over 18 who were admitted to certain hospital units due to suicide risk, can speak and write English fluently, and own a smartphone with internet. It aims to help those at high risk for suicide after they leave the hospital.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Unified Protocol-based treatment, with three sessions and use of a mobile app to manage suicidal thoughts and behaviors
Follow-up
Participants are monitored for changes in suicidal thoughts and self-efficacy for managing negative emotions
What Are the Treatments Tested in This Trial?
Interventions
- Mobile App
- Unified Protocol
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Massachusetts General Hospital
Collaborator
National Institute of Mental Health (NIMH)
Collaborator